| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tectonic Therapeutic, Inc. (TECX) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. TECX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 239.2K | $6.43M | - | |
| Other | 55.3K | $1.49M | - | |
| Other | 40.9K | $1.10M | - | |
| CFO | 28.1K | $755.6K | - | |
| Dir | 10.2K | $274.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2020 | MacKay Geoffrey | See Remarks | Sell | 1,400 | $29.07 | $40,691.98 | -0.4% | |
| Feb 11, 2020 | MacKay Geoffrey | See Remarks | Sell | 63,000 | $27.57 | $1,737,080.58 | -8.1% | |
| Feb 11, 2020 | Paige Christopher | Director | Sell | 15,000 | $28.00 | $420,000.00 | -5.6% | |
| Jan 28, 2020 | Paige Christopher | Director | Sell | 10,000 | $23.00 | $230,000.00 | -3.6% | |
| Jul 19, 2019 | Atlas Venture Fund X, L.P.69 | 10% Owner | Buy | 810,811 | $18.50 | $15,000,003.50 | +17.0% | |
| Jul 19, 2019 | Booth Bruce70 | Director | Buy | 810,811 | $18.50 | $15,000,003.50 | +17.0% | |
| Apr 8, 2019 | MacKay Geoffrey | See Remarks | Sell | 14,000 | $27.25 | $381,511.10 | -1.7% | |
| Apr 8, 2019 | Paige Christopher | Director | Sell | 10,000 | $25.72 | $257,196.12 | -0.9% |